We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-0.05%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$34.1B
AUM Growth
-$1.11B
(-3.1%)
Cap. Flow
-$521M
Cap. Flow
% of AUM
-1.53%
Top 10 Holdings %
Top 10 Hldgs %
23.76%
Holding
791
New
49
Increased
168
Reduced
395
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$73.6M |
| 2 |
Cisco
CSCO
|
+$63.8M |
| 3 |
ABB
ABB Ltd
ABB
|
+$60.9M |
| 4 |
Visa
V
|
+$59.5M |
| 5 |
Amazon
AMZN
|
+$59.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$288M |
| 2 |
ExxonMobil
XOM
|
+$65.3M |
| 3 |
Lowe's Companies
LOW
|
+$62.5M |
| 4 |
FRX
FOREST LABORATORIES INC
FRX
|
+$54.2M |
| 5 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$42.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.41% |
| 2 | Financials | 12.14% |
| 3 | Healthcare | 11.87% |
| 4 | Industrials | 7.92% |
| 5 | Consumer Discretionary | 7.72% |
Similar funds
CBU
BC
Loomis, Sayles & Company's Q3 2014 Portfolio in Review
As of Q3 2014, Loomis, Sayles & Company held 791 positions worth $34.1B, down 3.1% from $35.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Loomis, Sayles & Company's Q3 2014 filing shows 49 new, 168 increased, 395 reduced and 78 closed positions. Its largest new stake was ABB Ltd: 2,657,098 shares worth $59.5M. The largest sale was Vertex Pharmaceuticals, an estimated $288M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Loomis, Sayles & Company's largest Q3 2014 buy was ABB Ltd: 2,657,098 shares worth $59.5M.
- Loomis, Sayles & Company added most to Royal Dutch Shell PLC ADS Class A in Q3 2014, an estimated $73.6M increase.
- Loomis, Sayles & Company's biggest Q3 2014 reduction was ExxonMobil, cutting an estimated $65.3M.
- Loomis, Sayles & Company fully exited Vertex Pharmaceuticals in Q3 2014, selling an estimated $288M.
- Loomis, Sayles & Company's ten largest holdings make up 24% of its $34.1B portfolio in Q3 2014.
- Loomis, Sayles & Company opened 49 new positions and closed 78 in Q3 2014.
- Loomis, Sayles & Company's portfolio value fell 3.1% quarter-over-quarter to $34.1B.
Based on Loomis, Sayles & Company's 13F filing for Q3 2014, filed 14 Nov 2014.